Šálek Tomáš, Klhůfek Josef, Vodička Martin, Pšenčík Marek
Department of Clinical Biochemistry and Pharmacology, Tomas Bata Hospital in Zlín, Zlín, Czech Republic.
Institute of Clinical Biochemistry and Diagnostics, Medical Faculty in Hradec Králové, Charles University in Prague, Prague, Czech Republic.
Biochem Med (Zagreb). 2025 Oct 15;35(3):030902. doi: 10.11613/BM.2025.030902. Epub 2025 Aug 15.
The study aims to present a case study of a patient with supratherapeutic serum gentamicin concentration. An 83-year-old male was admitted to the Department of Internal Medicine for persistent loss of appetite, decompensated heart failure, and pneumonia. He was treated with 240 mg gentamicin daily alongside ampicillin/sulbactam penicillin antibiotic. The trough gentamicin concentrations and estimated glomerular filtration rate from creatinine (eGFRcrea) and cystatin C (eGFRcys) were performed. The patient had the supratherapeutic trough gentamicin concentration of 2.5 mg/L. eGFRcrea was 62 mL/min/1.73m and eGFRcys was 25 mL/min/1.73m. The difference between eGFRcrea and eGFRcys was 148%. Falsely high eGFRcrea in elderly patient led to the supratherapeutic gentamicin concentration even after the standard 240 mg gentamicin dose.
该研究旨在呈现一例血清庆大霉素浓度超治疗范围患者的病例研究。一名83岁男性因持续食欲不振、失代偿性心力衰竭和肺炎入住内科。他每天接受240毫克庆大霉素治疗,同时使用氨苄西林/舒巴坦青霉素抗生素。检测了庆大霉素谷浓度以及根据肌酐估算的肾小球滤过率(eGFRcrea)和胱抑素C估算的肾小球滤过率(eGFRcys)。该患者的庆大霉素谷浓度超治疗范围,为2.5毫克/升。eGFRcrea为62毫升/分钟/1.73平方米,eGFRcys为25毫升/分钟/1.73平方米。eGFRcrea与eGFRcys之间的差异为148%。老年患者中eGFRcrea的假性升高导致即使在使用标准的240毫克庆大霉素剂量后,庆大霉素浓度仍超治疗范围。